[Ip-health] Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection

Sophie Mayer sophie.emma.mayer at gmail.com
Fri Nov 9 08:51:05 PST 2012


"In an unusual move, a big drug company said on Thursday that it would
effectively cut in half the price of a new
cancer<http://health.nytimes.com/health/guides/disease/cancer/overview.html?inline=nyt-classifier>drug
after a leading cancer center said it would not use the drug because
it was too expensive."

Full story here:
http://www.nytimes.com/2012/11/09/business/sanofi-halves-price-of-drug-after-sloan-kettering-balks-at-paying-it.html?ref=health&_r=0

Original op-ed by Sloan-Kettering:
http://www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html



More information about the Ip-health mailing list